Shock! Biotech raises money

By Kate McDonald
Monday, 30 March, 2009

Melbourne stem cell company Mesoblast has raised $10.81 million through a private placement to existing as well as new and institutional investors.

The money will be used to further the company’s clinical trial programs, including its bone and cartilage regenerative products.

Mesoblast said the placement of 15.02 million shares was oversubscribed.

The money will come as a boost to the company’s cash reserves, which were $9.6 million as at December 31, 2008.

Related News

RSV immunisation program for babies slashes hospital stays

An Australian-first study has demonstrated the effectiveness of immunisation against respiratory...

A targeted treatment option for psoriasis

New research from MedUni Vienna paves the way for the development of a therapy that not only...

Maternal cannabis use puts kids at risk of behavioural problems

Children exposed to their mother's cannabis use during pregnancy and after birth are three...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd